Surgery Partners, Inc. (NASDAQ:SGRY) Stock Has Consensus Price Target of $19.00

Surgery Partners, Inc. (NASDAQ:SGRY) has received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $19.00.

SGRY has been the topic of a number of recent research reports. Weiss Ratings upgraded shares of Surgery Partners from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Surgery Partners in a research note on Friday, October 2nd. Raymond James Financial set a $18.00 price target on shares of Surgery Partners in a report on Tuesday, August 11th. JPMorgan Chase & Co. boosted their price objective on shares of Surgery Partners from $14.00 to $15.00 and gave the company a “neutral” rating in a research report on Monday, September 14th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $19.00 price objective on shares of Surgery Partners in a research note on Wednesday, September 30th.

Surgery Partners Stock Performance

NASDAQ SGRY opened at $14.71 on Tuesday. The company has a quick ratio of 1.78, a current ratio of 1.95 and a debt-to-equity ratio of 1.18. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $23.44. The business has a fifty day moving average of $14.17 and a 200-day moving average of $14.48. The stock has a market cap of $1.93 billion, a price-to-earnings ratio of -21.01, a price-to-earnings-growth ratio of 4.52 and a beta of 1.90.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.04. The business had revenue of $848.90 million for the quarter, compared to analyst estimates of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.17 earnings per share. As a group, analysts predict that Surgery Partners will post 0.25 earnings per share for the current fiscal year.

Insider Transactions at Surgery Partners

In other news, Director Teresa DeLuca bought 10,000 shares of the stock in a transaction on Tuesday, August 18th. The stock was purchased at an average cost of $14.35 per share, with a total value of $143,500.00. Following the purchase, the director owned 66,843 shares of the company’s stock, valued at approximately $959,197.05. The trade was a 17.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Company insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of SGRY. TD Waterhouse Canada Inc. lifted its stake in shares of Surgery Partners by 18.3% during the 3rd quarter. TD Waterhouse Canada Inc. now owns 196,887 shares of the company’s stock worth $2,601,000 after purchasing an additional 30,476 shares during the period. Squarepoint Ops LLC acquired a new stake in shares of Surgery Partners during the second quarter worth $308,000. Varde Management L.P. grew its position in shares of Surgery Partners by 32.8% in the second quarter. Varde Management L.P. now owns 1,003,447 shares of the company’s stock valued at $16,858,000 after purchasing an additional 248,009 shares during the period. Penn Capital Management Company LLC purchased a new stake in shares of Surgery Partners in the second quarter valued at $2,941,000. Finally, Hsbc Holdings PLC grew its position in shares of Surgery Partners by 54.5% in the second quarter. Hsbc Holdings PLC now owns 2,958,912 shares of the company’s stock valued at $48,912,000 after purchasing an additional 1,043,244 shares during the period.

About Surgery Partners

Surgery Partners, Inc (NASDAQ:SGRY) is a healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals in partnership with physicians and health systems. Its facilities provide scheduled surgical care in outpatient and inpatient settings, with an emphasis on procedures that generally do not require extended hospital stays.

The company supports a range of specialties, including orthopedics, pain management, ophthalmology, gastroenterology, gynecology, and general surgery.